Health ❯ Neurology

Parkinson's Disease

Symptoms Diagnosis Research Treatment Deep Brain Stimulation Risk Factors Exercise Therapy Specialist Dyskinesia Medical Consultation Progression Doctor Visits Treatment Innovations Genetic Variants Clinical Trials GTPases Concussion Research Concussion Management Stem Cell Therapy Lewy Bodies Chronic Traumatic Encephalopathy Movement Disorder Motor Symptoms Classification Biological Factors Causes Cognitive and Behavioral Side Effects Biomarkers Motor Disorders Ayurvedic Treatments Dopamine Neurons Habitual Behavior Cognitive Impairment Parkinson-plus Syndromes Dementia Inflammation Treatment Patient Care Chronic Illness Parkinson's Disease with Dementia Treatment Methods Medication Effects Environmental Factors Diagnostic Techniques Restless Leg Syndrome Treatment Options Management Caffeine Consumption Surgical Treatments Disease Progression Diagnostic Imaging Research Studies Medical Experts Botox Treatment Neurologist Visits

Ventyx’s NLRP3 Drug Cuts Inflammation Markers in Phase 2, Shares Soar

Strong biomarker reductions have investors eyeing a cardiovascular push for the oral NLRP3 candidate.

Study Finds Higher Parkinson's Risk Among People With Restless Leg Syndrome

Nationwide Study Links TCE in Outdoor Air to Higher Parkinson’s Risk

MRI-Compatible Ultrasound Helmet Modulates Deep Brain Activity in First Human Study

Study Links Fine Particle Pollution to Lewy Body Dementia and Identifies Toxic Protein Strain

Adaptive Cycling Alters Brain Activity in Parkinson’s Patients, Study Finds

University of Rochester Launches AI Voice Test for Early Parkinson’s Screening

Non-Invasive Sebum Swab Test Poised for Clinical Trials to Detect Parkinson’s Early

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial

AI Earwax Test Detects Parkinson’s Disease With 94% Accuracy